Radiation Oncology/RTOG Trials/0319
< Radiation Oncology < RTOG Trials
|
RTOG 03-19 (Breast)
- Title: A Phase I/II Trial to Evaluate 3D-CRT Confined to the Region of the Lumpectomy Cavity for Stage I and II Breast Carcinoma
- Objective:
- Protocol:
- 38.5 Gy Total/10 fractions (3.85 Gy per fraction), 2 fractions/day (separated by 6 hours), Given in 5 consecutive working days
- Radiotherapy should begin within eight weeks of surgery (If chemotherapy is given first, RT begins 2 weeks after the last cycle of chemotherapy)
- Eligibility:
- Invasive pathology; AJCC Stage I-II; single focus
- Negative surgical margin; up to 3 LN+
- Enrollment Target: 46 patients
- Activation: August 15, 2003
- Closed: April 30, 2004
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.